Science & Enterprise subscription

Follow us on Twitter

  • An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later ho… https://t.co/TupWwuG3ok
    about 18 hours ago
  • New post on Science and Enterprise: Home-Based Cancer Care Boosts Outcomes, Cuts Costs https://t.co/9zcrG432As #Science #Business
    about 18 hours ago
  • Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19...… https://t.co/nUXjHixhfe
    about 19 hours ago
  • A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received a… https://t.co/MOueVM6Nqj
    about 24 hours ago
  • New post on Science and Enterprise: NIH Funds Light-Aided Gene Therapy for Eye Disease https://t.co/CnDzdinH43 #Science #Business
    about 24 hours ago

Please share Science & Enterprise

Drug Maker Licenses Low-Dose Vaccine Patch

Nanopatch system

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

Infographic – Largest Ever U.S. Manufacturing Decline

The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped 13.7 percent from March. . . . → Read More: Infographic – Largest Ever U.S. Manufacturing Decline

Start-Up Gains Hydrogen Fuel Technology Funds

Fuel cell engine

A spin-off company from a university engineering lab received funds to build a device that efficiently splits water and creates hydrogen for fuel cell cars. . . . → Read More: Start-Up Gains Hydrogen Fuel Technology Funds

Venture Producing Covid-19 Antibody Test Kits

SARS-Cov-2 virus

A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies. . . . → Read More: Venture Producing Covid-19 Antibody Test Kits

Int’l Group Backs Novavax Covid-19 Vaccine

SARS-Cov-2 virus

A global consortium is funding a biotechnology company’s clinical trials and manufacturing plans for a vaccine protecting against Covid-19 viruses. . . . → Read More: Int’l Group Backs Novavax Covid-19 Vaccine

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Oxford, AstraZeneca Partner on Covid-19 Vaccine

Covid-19 vaccine infographic

AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford. . . . → Read More: Oxford, AstraZeneca Partner on Covid-19 Vaccine

Electronic Stockings Tested for Muscle Stimulation

Intensive care

Compression stockings, 3-D printed with electronic circuits woven in, will soon be tested among patients bed-ridden for long periods with Covid-19 infections. . . . → Read More: Electronic Stockings Tested for Muscle Stimulation

Moderna Gains $483M for Covid-19 Vaccine

SARS-Cov-2 virus

A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials. . . . → Read More: Moderna Gains $483M for Covid-19 Vaccine

Univ.-Led Consortium Produces Covid-19 Test Swabs

NP swabs

A group of academic researchers, manufacturers, and military labs created an FDA-approved nasal swab, now available in large quantities for Covid-19 testing. . . . → Read More: Univ.-Led Consortium Produces Covid-19 Test Swabs